VCA
DVAX

Verdence Capital Advisors’s Dynavax Technologies DVAX Stock Holding History

Verdence Capital Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,000
Closed -$167K – 503
2021
Q2 		$167K Buy
+17,000
New +$155K 0.02% 466

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Verdence Capital Advisors's DVAX Position: Q3 2021 in Review

Verdence Capital Advisors sold out of Dynavax Technologies (DVAX) in Q3 2021, closing a stake of 17,000 shares — an estimated $167K sold.

Verdence Capital Advisors first reported a position in DVAX in Q2 2021 and held it in 1 quarter. The position peaked at $167K in Q2 2021. 183 funds tracked by Wall St. Rank hold DVAX as of Q3 2021.

  • Verdence Capital Advisors reported no remaining Dynavax Technologies position as of Q3 2021 after selling out during the quarter.
  • Verdence Capital Advisors sold 17,000 Dynavax Technologies shares in Q3 2021, an estimated $167K.
  • Verdence Capital Advisors first reported a position in Dynavax Technologies in Q2 2021 and held it in 1 quarter.
  • Verdence Capital Advisors's Dynavax Technologies position peaked at $167K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2021.

Based on Verdence Capital Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.